{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:22:23Z","timestamp":1792700543642,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2025SF-YBXM-008"],"award-info":[{"award-number":["2025SF-YBXM-008"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070470"],"award-info":[{"award-number":["82070470"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82500502"],"award-info":[{"award-number":["82500502"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.metabol.2026.156757","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:49:53Z","timestamp":1787813393000},"page":"156757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hepatic MED1 disruption ameliorates obesity-related fatty liver by attenuating SREBP1-driven lipogenesis"],"prefix":"10.1016","volume":"184","author":[{"given":"Xulei","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhou","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangshuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weirong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2026.156757_bb0005","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.cmet.2023.06.012","article-title":"Nonalcoholic fatty liver disease mortality may not be decreasing: a need for careful interpretation of GBD 2019 estimates of liver deaths","volume":"35","author":"Paik","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156757_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2026.156757_bb0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000497124","article-title":"The ABCD of obesity: an EASO position statement on a diagnostic term with clinical and scientific implications","volume":"12","author":"Fruhbeck","year":"2019","journal-title":"Obes Facts"},{"key":"10.1016\/j.metabol.2026.156757_bb0020","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/hep.32228","article-title":"Global burden of NAFLD and chronic liver disease among adolescents and young adults","volume":"75","author":"Paik","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156757_bb0025","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156757_bb0030","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.cgh.2024.09.038","article-title":"Global epidemiology and characteristics of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes mellitus: an updated systematic review and meta-analysis","volume":"23","author":"Souza","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2026.156757_bb0035","first-page":"S10","article-title":"Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity","volume":"59","author":"Bansal","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2026.156757_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2026.156757_bb0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156757_bb0050","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cmet.2024.04.016","article-title":"New and emerging treatments for metabolic dysfunction-associated steatohepatitis","volume":"36","author":"Tincopa","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156757_bb0055","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","article-title":"Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis","volume":"169","author":"Younossi","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2026.156757_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100058","article-title":"Antiobesity medications in adult and pediatric obesity and metabolic dysfunction-associated steatotic liver disease","volume":"77","author":"Rodriguez","year":"2025","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.metabol.2026.156757_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156028","article-title":"The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus","volume":"161","author":"Zeng","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156757_bb0070","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.molcel.2020.12.040","article-title":"The corepressors GPS2 and SMRT control enhancer and silencer remodeling via eRNA transcription during inflammatory activation of macrophages","volume":"81","author":"Huang","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2026.156757_bb0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.molcel.2005.08.008","article-title":"Thyroid hormone-induced juxtaposition of regulatory elements\/factors and chromatin remodeling of Crabp1 dependent on MED1\/TRAP220","volume":"19","author":"Park","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2026.156757_bb0080","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S1097-2765(03)00391-5","article-title":"Coordination of p300-mediated chromatin remodeling and TRAP\/mediator function through coactivator PGC-1alpha","volume":"12","author":"Wallberg","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2026.156757_bb0085","article-title":"MED1 IDR deacetylation controls stress responsive genes through RNA Pol II recruitment","author":"Lin","year":"2025","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.metabol.2026.156757_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar3958","article-title":"Coactivator condensation at super-enhancers links phase separation and gene control","volume":"361","author":"Sabari","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.metabol.2026.156757_bb0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.aar4199","article-title":"Mediator and RNA polymerase II clusters associate in transcription-dependent condensates","volume":"361","author":"Cho","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.metabol.2026.156757_bb0100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41594-023-01027-2","article-title":"The mediator complex regulates enhancer-promoter interactions","volume":"30","author":"Ramasamy","year":"2023","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.metabol.2026.156757_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3727\/105221614X13919976902219","article-title":"Med1 subunit of the mediator complex in nuclear receptor-regulated energy metabolism, liver regeneration, and hepatocarcinogenesis","volume":"16","author":"Jia","year":"2014","journal-title":"Gene Expr"},{"key":"10.1016\/j.metabol.2026.156757_bb0110","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.semcdb.2011.07.026","article-title":"Mediator-dependent nuclear receptor function","volume":"22","author":"Chen","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.metabol.2026.156757_bb0115","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1074\/jbc.M107995200","article-title":"Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors","volume":"277","author":"Crawford","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156757_bb0120","doi-asserted-by":"crossref","first-page":"25500","DOI":"10.1074\/jbc.272.41.25500","article-title":"Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor","volume":"272","author":"Zhu","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156757_bb0125","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/417563a","article-title":"Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis","volume":"417","author":"Ge","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156757_bb0130","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.24155","article-title":"Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse","volume":"53","author":"Bai","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156757_bb0135","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1101\/gad.347583.120","article-title":"MED1 is a lipogenesis coactivator required for postnatal adipose expansion","volume":"35","author":"Jang","year":"2021","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2026.156757_bb0140","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1080\/15548627.2021.1899691","article-title":"MED1 mediator subunit is a key regulator of hepatic autophagy and lipid metabolism","volume":"17","author":"Zhou","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.metabol.2026.156757_bb0145","first-page":"543","article-title":"miR-146a improves hepatic lipid and glucose metabolism by targeting MED1","volume":"45","author":"Li","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.metabol.2026.156757_bb0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40168-021-01097-8","article-title":"Novel insights into the genetically obese (ob\/ob) and diabetic (db\/db) mice: two sides of the same coin","volume":"9","author":"Suriano","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.metabol.2026.156757_bb0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/bega.2002.0332","article-title":"Animal models of steatohepatitis","volume":"16","author":"Koteish","year":"2002","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.metabol.2026.156757_bb0160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ame2.12338","article-title":"Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease","volume":"6","author":"Ding","year":"2023","journal-title":"Anim Model Exp Med"},{"key":"10.1016\/j.metabol.2026.156757_bb0165","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2026.156757_bb0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.metabol.2026.156757_bb0175","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","article-title":"De novo lipogenesis in health and disease","volume":"63","author":"Ameer","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156757_bb0180","doi-asserted-by":"crossref","first-page":"28410","DOI":"10.1074\/jbc.M300553200","article-title":"Acetyl-CoA carboxylase beta gene is regulated by sterol regulatory element-binding protein-1 in liver","volume":"278","author":"Oh","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156757_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156487","article-title":"Suppression of hepatosteatosis by isarubrolone C through AMPK-dependent regulation of lipophagy and lipid metabolism","volume":"176","author":"Chen","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156757_bb0190","doi-asserted-by":"crossref","first-page":"29341","DOI":"10.1074\/jbc.M802477200","article-title":"Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN)","volume":"283","author":"Choi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156757_bb0195","doi-asserted-by":"crossref","DOI":"10.1172\/JCI200522","article-title":"Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109","volume":"136","author":"Qu","year":"2026","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2026.156757_bb0200","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cmet.2023.03.013","article-title":"DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates","volume":"35","author":"Qu","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156757_bb0205","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.ajpath.2015.01.018","article-title":"PPARalpha-deficient Ob\/Ob obese mice become more obese and manifest severe hepatic steatosis due to decreased fatty acid oxidation","volume":"185","author":"Gao","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2026.156757_bb0210","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2026.156757_bb0215","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmet.2024.03.016","article-title":"Loss of GPR75 protects against non-alcoholic fatty liver disease and body fat accumulation","volume":"36","author":"Leeson-Payne","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156757_bb0220","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2026.156757_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2026.156757_bb0230","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease","volume":"158","author":"Azzu","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2026.156757_bb0235","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1136\/gutjnl-2020-322509","article-title":"Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis","volume":"70","author":"Koh","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2026.156757_bb0240","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cmet.2025.01.016","article-title":"Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism","volume":"37","author":"Jiang","year":"2025","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156757_bb0245","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2337\/db09-1380","article-title":"Glycerol-3-phosphate acyltransferase 1 deficiency in ob\/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity","volume":"59","author":"Wendel","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156757_bb0250","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156757_bb0255","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.metabol.2026.156757_bb0260","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1101\/gad.346791.120","article-title":"Critical roles of transcriptional coactivator MED1 in the formation and function of mouse adipose tissues","volume":"35","author":"Ito","year":"2021","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2026.156757_bb0265","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajpath.2022.03.013","article-title":"MED1 deficiency in macrophages aggravates isoproterenol-induced cardiac fibrosis in mice","volume":"192","author":"Fatima","year":"2022","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2026.156757_bb0270","first-page":"1529","article-title":"Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression","volume":"38","author":"Sekiya","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156757_bb0275","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2026.156757_bb0280","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-24-0115","article-title":"The role of adipose tissue dysfunction in hepatic insulin resistance and T2D","volume":"262","author":"Sancar","year":"2024","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2026.156757_bb0285","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s40001-024-02176-w","article-title":"Crosstalk between fat tissue and muscle, brain, liver, and heart in obesity: cellular and molecular perspectives","volume":"29","author":"Jia","year":"2024","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.metabol.2026.156757_bb0290","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.metabol.2026.156757_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155720","article-title":"The ubiquitin-like modifier FAT10 is induced in MASLD and impairs the lipid-regulatory activity of PPARalpha","volume":"151","author":"Clavreul","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156757_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155937","article-title":"Obesity and MASLD: is weight loss the (only) key to treat metabolic liver disease?","volume":"157","author":"Huttasch","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156757_bb0305","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2026.156757_bb0310","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s42255-022-00568-y","article-title":"Ammonia stimulates SCAP\/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth","volume":"4","author":"Cheng","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2026.156757_bb0315","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmet.2020.11.013","article-title":"Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques","volume":"33","author":"Tang","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156757_bb0320","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/19789","article-title":"Composite co-activator ARC mediates chromatin-directed transcriptional activation","volume":"398","author":"Naar","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156757_bb0325","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1101\/gad.10.22.2903","article-title":"SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein","volume":"10","author":"Oliner","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2026.156757_bb0330","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/BJ20120861","article-title":"Regulation of hepatic insulin sensitivity by activating signal co-integrator-2","volume":"447","author":"Kim","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2026.156757_bb0335","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41420-024-01944-1","article-title":"MED15 is upregulated by HIF-2alpha and promotes proliferation and metastasis in clear cell renal cell carcinoma via activation of SREBP-dependent fatty acid synthesis","volume":"10","author":"Hua","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.metabol.2026.156757_bb0340","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049650","article-title":"Cdk8 attenuates lipogenesis by inhibiting SREBP-dependent transcription in Drosophila","volume":"15","author":"Li","year":"2022","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.metabol.2026.156757_bb0345","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2337\/db13-0835","article-title":"Inhibition of SREBP transcriptional activity by a boron-containing compound improves lipid homeostasis in diet-induced obesity","volume":"63","author":"Zhao","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156757_bb0350","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nature04942","article-title":"An ARC\/mediator subunit required for SREBP control of cholesterol and lipid homeostasis","volume":"442","author":"Yang","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156757_bb0355","doi-asserted-by":"crossref","first-page":"H314","DOI":"10.1152\/ajpheart.00580.2018","article-title":"Disruption of cardiac Med1 inhibits RNA polymerase II promoter occupancy and promotes chromatin remodeling","volume":"316","author":"Hall","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:37:23Z","timestamp":1791520643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526002702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":71,"alternative-id":["S0026049526002702"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156757","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic MED1 disruption ameliorates obesity-related fatty liver by attenuating SREBP1-driven lipogenesis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156757"}}